HOME >> MEDICINE >> NEWS
First-degree fetal heart block may be reversible

There is an increased risk of fetal heart problems when mothers carry particular antibodies associated with rheumatic diseases, according to an abstract presented by Yale School of Medicine researchers at the Society for Maternal-Fetal Medicine Conference February 9 in San Francisco.

Congenital heart block (CHB) is present at or before birth and impairs the heart's electrical signaling from the upper to the lower chambers. CHB carries a 20 percent death rate and nearly all survivors require pacemakers. Joshua Copel, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale helped conduct the PR Interval and Dexamethasone Evaluation (PRIDE) study with a team of other researchers to evaluate an early marker of cardiac injury before there is permanent scarring.

The PRIDE group conducted a longitudinal (observational) study following over 100 women with the anti-Ro and anti-La antibodies to determine if there were early signs of fetal heart problems. They also explored whether early treatment would reverse the problems.

The team found that while first-degree fetal heart block may be reversible with the steroid drug dexamethasone, the condition could advance within as little as one week to a third-degree block, which is irreversible even with further intervention.

"Given the high recurrence rate we confirmed in this study, close monitoring and the earliest possible marker is necessary," said Copel, who plans trials of other possible treatments. "Advanced block and permanent heart damage can occur within one week of a normal echocardiogram, even a weekly evaluation may not be sufficient to detect early onset of disease."


'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
9-Feb-2007


Page: 1

Related medicine news :

1. Benchmark fetal surgery study finds timeliness to be critical factor in success of treatment
2. Restricted fetal growth increases risk of irritable bowel syndrome
3. Improvement seen in fetal survival following preeclampsia
4. Methamphetamine use restricts fetal growth, study finds
5. Commonly used drug may prevent fetal alcohol syndrome
6. New eye movement test may help treat fetal alcohol syndrome
7. Lifestyle, rather than fetal or childhood factors, critical for adult bone health
8. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
9. Drug for cluster headaches may cause heart problems
10. Reductive stress linked to heart disease
11. Novel candidate biomarker for heart failure also strongly predicts risk of death

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... ... 06, 2019 , ... Allegheny Health Network (AHN) has named Kymberly Gyure, MD, ... WVU Medicine in May 2018, previously served as AHN’s Vice Chair of Pathology and ... October and is also part of the pathology faculty at Drexel University College of ...
(Date:12/6/2019)... ... 2019 , ... Brain Sentinel, Inc. announces it is hosting ... Annual Meeting. The symposium, “Fundamentals of Quantitative Surface Electromyography (sEMG) for Long-Term Monitoring”, ... during ictal events;, 2. Review specific sEMG patterns of motor seizures and the ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... resolution ultrasound (HRUS) technology to help their patients more easily detect ruptured silicone ... participating in this study and reporting on his experience. While the FDA currently ...
(Date:12/5/2019)... ... December 05, 2019 , ... Intelligent.com, a trusted resource for ... Degree Programs for 2020. The comprehensive research guide is based on an assessment ... based on curriculum quality, graduation rate, reputation, and post-graduate employment. , The ...
(Date:12/4/2019)... ... December 04, 2019 , ... A November 12 article on NBC ... public transit options. The article highlighted the life-changing or life-ending consequences of some E-scooter ... to a rider fatality after an incident with a vehicle. Los Angeles-based personal injury ...
Breaking Medicine News(10 mins):
(Date:12/6/2019)... PORTLAND, Ore. (PRWEB) , ... December 06, 2019 ... ... company focused on development of treatments for psychiatric and neurodegenerative disorders, announced today ... Drug (IND) application for NBTX-001 Inhaler, allowing the Company to initiate its Phase ...
(Date:12/6/2019)... ... December 06, 2019 , ... Plant ... Fruit Garden Supply LLC (a division of Horticultural Holdings LLC) to recommend Plant ... growers. , FFGS is a team of disciplined and energetic plant lovers ...
(Date:12/5/2019)... ... 2019 , ... nView, a leading behavioral health solutions company, ... Chief Product Officer. As the company expands its portfolio of software solutions, Rosenbaum ... market into nView’s product and company growth strategy. Rosenbaum will report directly to ...
Breaking Medicine Technology:
Cached News: